Patients developing secondary myelodysplasia after autografting
UPN . | Cycles of fludarabine . | Additional therapy . | Time between transplantation and MDS, mo . |
|---|---|---|---|
| 0152 | 6 | Cyclophosphamide | 30 |
| 0176 | 6 | Nil | 28 |
| 0115 | 5 | Nil | < 20 |
| 0109 | 4 | COP, 2 cycles | 32 |
| 0108 | 6 | Nil | 70 |
UPN . | Cycles of fludarabine . | Additional therapy . | Time between transplantation and MDS, mo . |
|---|---|---|---|
| 0152 | 6 | Cyclophosphamide | 30 |
| 0176 | 6 | Nil | 28 |
| 0115 | 5 | Nil | < 20 |
| 0109 | 4 | COP, 2 cycles | 32 |
| 0108 | 6 | Nil | 70 |
UPN indicates unique patient number; COP, cyclophosphamide, Oncovin, prednisone.